Abstract
Background: Recent evidences suggest that hypertension is the most common underlying comorbid among COVID-19 patients, which often occurs in adults who are at higher risk of being infected with the SARS-CoV-2 virus and experiencing severe symptoms. Hypertension is also commonly accompanied by many comorbidities that will further compromised the clinical presentation of COVID-19 patients. Determination and appropriate management of hypertension and its comorbidities would be an important aspect during the pandemic Objective: The aims of this study is to define the characteristics and comorbidities among hypertensive patients in outpatient settings during pandemic era. Methods: This descriptive cross-sectional study included 108 medical records of patients with hypertension diagnosis in outpatient cardiology clinic, at Sanglah General Hospital in January 2021. Result: Among 108 subjects, there was male predominance (57.4%) with mean of age 54.07 years old. About 23.1% subjects were active smokers and 61.1% were overweight/obese. The most common comorbidities that was found on subjects was Coronary Artery Disease (50%), which was followed by heart failure (27.8%) and Diabetes Mellitus (14.8%). Blood pressure was controlled only in 39.8% patients. The patients most commonly took combination therapy (74.1%), with calcium channel blocker (CCB) was the most used pharmacotherapy (81.5%). Conclusion: Hypertension and its comorbidities were important predictors of poor outcome among COVID-19 patients. Therefore, optimal therapy and control for all risk factors during this pandemic are mandatory, regarding the benefit for morbidity and mortality.